Liskiewicz, A. ; Müller, T.D.
Regulation of energy metabolism through central GIPR signaling.
Peptides 176:171198 (2024)
Moser, C.* ; Gosselé, K.A.* ; Balaz, M.* ; Balázová, L.* ; Horvath, C.* ; Künzle, P.* ; Okreglicka, K.M.* ; Li, F.* ; Blüher, M. ; Stierstorfer, B.* ; Hess, E.* ; Lamla, T.* ; Hamilton, B.* ; Klein, H.* ; Neubauer, H.* ; Wolfrum, C.* ; Wolfrum, S.*
FAM3D: A gut secreted protein and its potential in the regulation of glucose metabolism.
Peptides 167:171047 (2023)
Novikoff, A. ; Müller, T.D.
The molecular pharmacology of glucagon agonists in diabetes and obesity.
Peptides 165:171003 (2023)
Schavinski, A.Z.* ; Machado, J. ; Morgan, H.J.N.* ; Lautherbach, N.* ; Paula-Gomes, S.* ; Kettelhut, I.C.* ; Navegantes, L.C.C.*
Calcitonin gene-related peptide exerts inhibitory effects on autophagy in the heart of mice.
Peptides 146:170677 (2021)
Barbosa-Yañez, R.L.* ; Markova, M.* ; Dambeck, U.* ; Honsek, C.* ; Machann, J. ; Schüler, R.* ; Kabisch, S.* ; Pfeiffer, A.F.H.*
Predictive effect of GIPR SNP rs10423928 on glucose metabolism liver fat and adiposity in prediabetic and diabetic subjects.
Peptides 125:170237 (2020)
Knerr, P.J.* ; Mowery, S.A.* ; Finan, B.* ; Perez-Tilve, D.* ; Tschöp, M.H. ; DiMarchi, R.D.*
Selection and progression of unimolecular agonists at the GIP, GLP-1, and glucagon receptors as drug candidates.
Peptides 125:170225 (2020)
Brandt, S. ; Götz, A. ; Tschöp, M.H. ; Müller, T.D.
Gut hormone polyagonists for the treatment of type 2 diabetes.
Peptides 100, 190-201 (2018)
Brandt, S. ; Mayer, J.P.* ; Ford, J.* ; Gelfanov, V.M.* ; DiMarchi, R.D.*
Controlled intramolecular antagonism as a regulator of insulin receptor maximal activity.
Peptides 100, 18-23 (2018)
Poher, A.-L. ; Tschöp, M.H. ; Müller, T.D.
Ghrelin regulation of glucose metabolism.
Peptides 100, 236-242 (2018)
Santiago, J.C. ; Otto, M.* ; Kern, W.* ; Baier, P.C.* ; Hallschmid, M.
Relationship between cerebrospinal fluid concentrations of orexin A/hypocretin-1 and body composition in humans.
Peptides 102, 26-30 (2018)
Day, J.W.* ; Gelfanov, V.* ; Smiley, D.* ; Carrington, P.E.* ; Eiermann, G.* ; Chicchi, G.* ; Erion, M.D.* ; Gidda, J.* ; Thornberry, N.A.* ; Tschöp, M.H. ; Marsh, D.J.* ; SinhaRoy, R.* ; DiMarchi, R.* ; Pocai, A.*
Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents.
Peptides 98, 443-450 (2012)
Al-Massadi, O.* ; Tschöp, M.H. ; Tong, J.*
Ghrelin acylation and metabolic control.
Peptides 32, 2301-2308 (2011)
Haidan, A.* ; Hilbers, U.* ; Bornstein, S.R.* ; Ehrhart-Bornstein, M.*
Human adrenocortical NCI-H295 cells express VIP receptors. Steroidogenic effect of vasoactive intestinal peptide (VIP).
Peptides 19, 1511-1517 (1998)
Breidert, M.* ; Bornstein, S.R.* ; Ehrhart-Bornstein, M.* ; Scherbaum, W.A.* ; Holst, J.J.*
Angiotensin II regulates both adrenocortical and adrenomedullary function in isolated perfused pig adrenals.
Peptides 17, 287-292 (1996)